

<!DOCTYPE html>

<html lang="ru-UZ">
<head>
   <!-- Global site tag (gtag.js) - Google Analytics -->
   <script async src="https://www.googletagmanager.com/gtag/js?id=UA-2682682-1"></script>
   <script>
      window.dataLayer = window.dataLayer || [];
      function gtag() { dataLayer.push(arguments); }
      gtag('js', new Date());
      gtag('config', 'UA-2682682-1');
   </script>
<title>

</title><meta charset="UTF-8" /><meta http-equiv="content-type" content="text/html; charset=UTF-8" /><meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.3, maximum-scale=3.0" /><link href="/css/mactform.css" rel="stylesheet" type="text/css" />

    <style type="text/css">
        /*.contents-caption DIV {
            float: right;
        }*/

        /*.mobilnav TD {
            height: 32px;
        }*/

        /*.mobilnav {
            border: 0px;
            padding: 0;
            background: url('/image/h-menu.gif') repeat-x scroll left top transparent;
        }*/

        body {
            margin: 0;
        }

        td {
            min-height: 22px;
        }

        /*#userComments {
            position: fixed;
            top: 0;
            left: 200px;
            width: 279px;
            height: 18px;
            background-color: Black;
            color: White;
            z-index: 2000;
            padding: 3px;
            display: none;
        }*/

        /*#fancybox_div {
            display: none;
        }*/

        /*#divContextRasporka {
            width: 270px;
        }*/

        /*#tddivContext {
            background-color: White;
        }*/

        /*#backButton {
            color: White;
            font-weight: bold;
            text-decoration: none;
        }*/

        /*#divCont {
            padding-top: 35px;
        }*/

        /*.main_menu ul .checkboxArea, .main_menu ul .checkboxAreaChecked {
            padding-top: 12px;
        }*/

        /*#item3 > ul > li {
            white-space: nowrap;
        }*/

        /*header > nav > ul > li > a {
            font-family: Arial;
            font-size: 11px;
        }*/

        /*#actContent a {
            font-size: 14px;
            font-family: Arial;
        }*/

        /*#selected_div {
            height: 250px;
            overflow: auto;
            padding: 6px 1px 1px 9px;
        }*/

        /*.enter_submit {
            background: url("/images/bg/search_button_bg.jpg") repeat-x scroll 0 0 transparent;
            border: 1px solid #7190EE;
            border-radius: 6px 6px 6px 6px;
            float: right;
            margin-right: 2px;
            cursor: pointer;
        }*/

        /*.enter_submit > div {
                background: url("/images/arrow/button_uzor4_left.png") no-repeat scroll 4px 7px transparent;
                float: left;
                width: 100%;
                cursor: pointer;
            }*/

        /*.enter_submit input[type="button"] {
                background: url("/images/arrow/button_uzor4_right.png") no-repeat scroll right 7px transparent;
                border: medium none;
                border-radius: 6px 6px 6px 6px;
                color: #FFFFFF;
                float: left;
                font-size: 12px;
                font-weight: bold;
                height: 21px;
                margin-left: 22px;
                margin-right: 4px;
                padding: 0 22px 3px 0;
                cursor: pointer;
            }*/

        .show_context {
            background-color: #FFFF00;
            color: inherit;
        }
    </style>
    <style id="tree_style" type="text/css">
        #divAct a, #divAct DIV, #divAct font, div#theDefCssID table td, th {
            font-size: 12pt;
        }
    </style>

    <script type="text/javascript" charset="utf-8">
        //window.onbeforeunload = function () {
        //    //document.getElementById("main_container").innerHTML = "";
        //    //window.body.style.background = "red";  //css("background", "red");
        //    //window.scrollTo(0, 0);
        //}

        window.onload = function () {
            setTimeout(function () { scrolPage(); }, 100);
        }

        function scrolPage() {
            var hash = location.hash.toString();
            if (hash.length > 2) {
                var elem = document.getElementById(location.hash.toString().substring(1));
                if (elem === null || elem === undefined) {
                    document.body.scrollTop = document.documentElement.scrollTop = 0;
                }
                else {
                    document.body.scrollTop = document.documentElement.scrollTop = elem.offsetTop - 10;
                }
            }
            else {
                document.body.scrollTop = document.documentElement.scrollTop = 0;
            }
        }
    </script>
</head>
<body>
    
    <a href="#DynContent" id="DynContentBtn"></a>
    <div style="display: none;">
        <div id="DynContent" style="width: 350px;">
            <table>
                <tr>
                    <td><span id="dynText"></span></td>
                </tr>
            </table>
        </div>
    </div>
    <div id="headcont">
        
        <header style="z-index: 2000;" id="headermenu">
            <div class='logo' style="padding: 0px 0px 0px 8px">
                <a href='/ru/'><span></span></a>
            </div>
        </header>
        
    </div>
    <div id='main_container'>
        
        <section class='main_text'>
            <table style="width: 100%; font-family: Arial; font-size: 14px; font-weight: bold;">
                <tr>
                    <td style="width: 50%">
                        
                        
                        
                    </td>
                    <td style="width: 50%; text-align: right">
                        
                        
                    </td>
                </tr>
            </table>
            <div id="divAct" style="margin: 0px; padding: 0px 5px 0px 5px; background: white;">
                
                <div id="divCont" style="background:#ffffff;border:none;margin:auto;"><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6252758">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5988"></label><a id="onLS-6252758">[<b>TSZ:</b><div id="LS3698"><span class="iorRN">1.</span><span class="iorVal">Ijtimoiy-madaniy masalalar / Ijtimoiy sugʻurta, ijtimoiy taʼminot va ijtimoiy himoya;</span></div><div id="LS3700"><span class="iorRN">2.</span><span class="iorVal">Ijtimoiy-madaniy masalalar / Sogʻliqni saqlash. Sanitariyaga oid qonun hujjatlari]</span></div></a></div><div class="ACCEPTING_BODY"><a id="-6253755">Oʻzbekiston Respublikasi Prezidentining</a></div><div class="ACT_FORM"><a id="-6253756">Qarori</a></div><div class="ACT_TITLE"><a id="-6253757">Aholini sifatli dori vositalari va tibbiy buyumlar bilan taʼminlash yuzasidan qoʻshimcha chora-tadbirlar toʻgʻrisida</a></div><div class="BY_DEFAULT"><a id="-6253759"></a></div><div class="ACT_TEXT"><a id="-6253760">Aholi va tibbiyot tashkilotlarining sifatli dori vositalari hamda tibbiy buyumlar bilan taʼminlanganlik darajasini oshirish, sohada taʼsirchan jamoatchilik nazoratini olib borish uchun shart-sharoitlar yaratish, shuningdek, 2022-yil 18-mart kuni oʻtkazilgan Oʻzbekiston Respublikasi Prezidentining sogʻliqni saqlash sohasi vakillari bilan “Tibbiyotdagi islohotlar — inson qadri uchun” mavzusidagi ochiq muloqoti doirasida belgilangan vazifalar ijrosini taʼminlash maqsadida:</a></div><div class="ACT_TEXT"><a id="-6253761">1. Shunday tartib oʻrnatilsinki, unga muvofiq 2023-yil 1-yanvardan boshlab:</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7711065"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253762">Oldingi</a> tahrirga qarang.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7711065">(1-bandning “a” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2025-yil 19-avgustdagi PF-137-sonli <a href="/ru/acts/-7697210?ONDATE=23.08.2025 00#-7704299">Farmoniga </a>asosan chiqarilgan — Qonunchilik maʼlumotlari milliy bazasi, 23.08.2025-y., 06/25/137/0777-son)</a></div><div class="ACT_TEXT"><a id="-6253765">b) quyidagilar bekor qilinadi:</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253766">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253766">retseptsiz beriladigan dori vositalarining roʻyxatini Sogʻliqni saqlash vazirligi tomonidan tasdiqlash. Bunda, dori vositalarining retsept boʻyicha va retseptsiz berilishi ularning tibbiyotda qoʻllanilishiga doir yoʻriqnomalarda belgilangan tartibda amalga oshiriladi;</a></div><div class="ACT_TEXT"><a id="-6253767">dori moddalarini (substansiyalarni) davlat roʻyxatidan oʻtkazish;</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253768">[<b>OKOZ:</b><div id="LBC6866"><span class="iorRN">1.</span><span class="iorVal">09.00.00.00 Tadbirkorlik va xoʻjalik faoliyati / 09.07.00.00 Standartlashtirish. Metrologiya. Sertifikatlash / 09.07.01.00 Standartlashtirish / 09.07.01.01 Umumiy qoidalar]</span></div></a></div><div class="ACT_TEXT"><a id="-6253768">Oʻzbekiston Respublikasidan tashqarida amalga oshirilgan dori vositalarining roʻyxatdan oʻtkazish natijalarini tan olishda standart namunalarini talab etish;</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253769">[<b>OKOZ:</b><div id="LBC6474"><span class="iorRN">1.</span><span class="iorVal">06.00.00.00 Ijtimoiy taʼminot va ijtimoiy sugʻurta toʻgʻrisidagi qonunchilik. Ijtimoiy himoya / 06.02.00.00 Ijtimoiy taʼminot va ijtimoiy sugʻurtani boshqarish;</span></div><div id="LBC7382"><span class="iorRN">2.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253769">v) Davlat tibbiy sugʻurtasi jamgʻarmasi orqali moliyalashtiriladigan respublika darajasidagi davlat statsionar tibbiyot muassasalarida (keyingi oʻrinlarda — shifoxonalar) bemorlarni dori vositalari va tibbiy buyumlar bilan taʼminlash shifoxona orqali amalga oshiriladi. Bunda, alohida holatlarda shifoxonada bemorlar tomonidan olib kelingan dori vositalar va tibbiy buyumlarni ishlatishga ruxsat berish tartibi Sogʻliqni saqlash vazirligi tomonidan belgilanadi.</a></div><div class="ACT_TEXT"><a id="-6253770">2. Belgilab qoʻyilsinki:</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253771">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253771">a) bemorlarni shifoxonada dori vositalari va tibbiy buyumlar bilan taʼminlash:</a></div><div class="ACT_TEXT"><a id="-6253772">dastlab respublika darajasidagi shifoxonalarda 2023-yil davomida tajriba-sinov tariqasida amalga oshiriladi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7359388"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253773">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7359388"></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-7359389">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-7359389">ularga xarajatlar smetasi boʻyicha ajratilishi koʻzda tutilgan mablagʻlar hisobidan kafolatlangan tibbiy xizmatlar va dori vositalari paketi doirasida xarid qilinadigan dori vositalari va tibbiy buyumlar bepul, qolgan hollarda pullik asosda shifoxonaga kirim qilingan narxlarda amalga oshiriladi. Bunda shifoxona tomonidan xarid qilinadigan retsept bilan beriladigan dori vositalarining narxi belgilangan ulgurji referent narxlaridan yuqori boʻlmasligi lozim;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7359397">(2-band “a” kichik bandining uchinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2025-yil 28-yanvardagi PF-13-sonli <a href="/ru/acts/-7345588?ONDATE=29.01.2025 00#-7351148">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.01.2025-y., 06/25/13/0080-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7359398"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253774">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7359398"></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-7359399">[<b>OKOZ:</b><div id="LBC6873"><span class="iorRN">1.</span><span class="iorVal">09.00.00.00 Tadbirkorlik va xoʻjalik faoliyati / 09.07.00.00 Standartlashtirish. Metrologiya. Sertifikatlash / 09.07.03.00 Sertifikatlashtirish / 09.07.03.01 Umumiy qoidalar]</span></div></a></div><div class="ACT_TEXT"><a id="-7359399">b) 2025-yil 1-apreldan boshlab referent narxlari qayd etilmagan yoki qayd etilgan narxdan yuqori boʻlgan retsept bilan beriladigan dori vositalarini sertifikatlashtirish taqiqlanadi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7359400">(2-bandning “b” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2025-yil 28-yanvardagi PF-13-sonli <a href="/ru/acts/-7345588?ONDATE=29.01.2025 00#-7351155">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.01.2025-y., 06/25/13/0080-son)</a></div><div class="ACT_TEXT"><a id="-6253775">3. Sogʻliqni saqlash vazirligi 2022-yil yakuniga qadar:</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7711066"><a href="/ru/acts/-6252758?ONDATE=05.12.2024 00#-7256466">Oldingi</a> tahrirga qarang.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7711066">(3-bandning “a” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2025-yil 19-avgustdagi PF-137-sonli <a href="/ru/acts/-7697210?ONDATE=23.08.2025 00#-7704299">Farmoniga </a>asosan chiqarilgan — Qonunchilik maʼlumotlari milliy bazasi, 23.08.2025-y., 06/25/137/0777-son)</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253777">[<b>OKOZ:</b><div id="LBC7381"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.03.00 Aholiga davolash-profilaktika yordami koʻrsatish / 14.01.03.07 Davolash-profilaktika yordamining boshqa turlari;</span></div><div id="LBC7382"><span class="iorRN">2.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253777">b) bemorlarni davolash uchun talab etiladigan dori vositalari va tibbiy buyumlarning toʻliq shifoxona tomonidan xarid qilinishini inobatga olib:</a></div><div class="ACT_TEXT"><a id="-6253778">shifoxonalarda dori vositalari va tibbiy buyumlar xaridi boʻyicha mutaxassis lavozimi joriy etilishini;</a></div><div class="ACT_TEXT"><a id="-6253779">shifoxonalar tomonidan birlamchi zarur boʻladigan zaxiraning Davlat budjeti va budjetdan tashqari mablagʻlar hisobidan shakllantirilishini taʼminlasin;</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253780">[<b>OKOZ:</b><div id="LBC7278"><span class="iorRN">1.</span><span class="iorVal">12.00.00.00 Axborot va axborotlashtirish / 12.03.00.00 Axborot resurslari. Axborot resurslaridan foydalanish / 12.03.02.00 Axborotni hujjatlashtirish. Elektron hujjat aylanishi / 12.03.02.01 Elektron hujjat aylanishi]</span></div></a></div><div class="ACT_TEXT"><a id="-6253780">v) Davlat budjeti va budjetdan tashqari mablagʻlar hisobidan xarid qilingan dori vositalari va tibbiy buyumlarning kunlik qoldigʻi hamda narxlari manbalar kesimida shifoxonalarning rasmiy veb-saytlarida joylashtirilishini hamda muntazam yangilab borilishini taʼminlasin.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253781">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253781">4. Shifoxonalar tomonidan dori vositalari va tibbiy buyumlarning xaridi uchun toʻlovlar budjet tizimi budjetlari xarajatlari tasnifining I guruh xarajatlari uchun belgilangan muddatlarda ham amalga oshirilishiga ruxsat berilsin.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253782">[<b>OKOZ:</b><div id="LBC6555"><span class="iorRN">1.</span><span class="iorVal">07.00.00.00 Moliya va kredit toʻgʻrisidagi qonunchilik. Bank faoliyati / 07.05.00.00 Respublika budjeti / 07.05.10.00 Budjet jarayoni]</span></div></a></div><div class="ACT_TEXT"><a id="-6253782">Moliya vazirligi Sogʻliqni saqlash vazirligining asoslangan hisob-kitoblariga muvofiq shifoxonalarni dori vositalari va tibbiy buyumlar bilan uzluksiz taʼminlash uchun talab etiladigan zarur mablagʻlar har yili Davlat budjeti parametrlarida koʻzda tutilishini taʼminlasin.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253783">[<b>OKOZ:</b><div id="LBC18898"><span class="iorRN">1.</span><span class="iorVal">01.00.00.00 Konstitutsiyaviy tuzum / 01.18.00.00 Jamoatchilik nazorati]</span></div></a></div><div class="ACT_TEXT"><a id="-6253783">5. Belgilansinki, dori vositalarining chakana savdosida jamoatchilik nazoratini joriy etish maqsadida 2023-yil 1-maydan boshlab:</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7359401"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253784">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7359401"></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-7359402">[<b>OKOZ:</b><div id="LBC7278"><span class="iorRN">1.</span><span class="iorVal">12.00.00.00 Axborot va axborotlashtirish / 12.03.00.00 Axborot resurslari. Axborot resurslaridan foydalanish / 12.03.02.00 Axborotni hujjatlashtirish. Elektron hujjat aylanishi / 12.03.02.01 Elektron hujjat aylanishi]</span></div></a></div><div class="ACT_TEXT"><a id="-7359402">jismoniy shaxslar tomonidan sotib olingan retsept bilan beriladigan dori vositalari uchun dorixonalar tomonidan taqdim etiladigan xarid chekining fiskal belgisi matritsali shtrix kod (QR-kod) yordamida skanerlash orqali soliq organlarining maxsus mobil ilovasida roʻyxatdan oʻtkazilganda retsept bilan beriladigan dori vositalari narxlari “Farmatsevtika mahsulotlari xavfsizligi markazi” davlat muassasasining axborot tizimidagi dori vositalarining chakana referent narxlari bilan avtomatik tarzda solishtiriladi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7359403">(5-bandning ikkinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2025-yil 28-yanvardagi PF-13-sonli <a href="/ru/acts/-7345588?ONDATE=29.01.2025 00#-7351157">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.01.2025-y., 06/25/13/0080-son)</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253785">[<b>OKOZ:</b><div id="LBC7278"><span class="iorRN">1.</span><span class="iorVal">12.00.00.00 Axborot va axborotlashtirish / 12.03.00.00 Axborot resurslari. Axborot resurslaridan foydalanish / 12.03.02.00 Axborotni hujjatlashtirish. Elektron hujjat aylanishi / 12.03.02.01 Elektron hujjat aylanishi]</span></div></a></div><div class="ACT_TEXT"><a id="-6253785">matritsali shtrix kod (QR-kod) yordamida skanerlash natijasida dori vositalarining chakana narxlariga belgilangan ustamalar oshirib qoʻllanilganligi aniqlangan taqdirda, tegishli chora koʻrish uchun bu haqida isteʼmolchilar huquqlarini himoya qilish uchun maxsus vakolat berilgan davlat organiga avtomatik ravishda xabar yuboriladi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7359404"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253786">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7359404"></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-7359405">[<b>OKOZ:</b><div id="LBC8805"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.15.00 Sogʻliqni saqlash toʻgʻrisidagi qonunchilik hujjatlarini buzganlik uchun javobgarlik]</span></div></a></div><div class="ACT_TEXT"><a id="-7359405">xarid cheki boʻyicha narx retsept bilan beriladigan dori vositasining chakana referent narxidan ortiq deb topilganda, ushbu maʼlumot asosida oʻtkazilgan tekshirish yakuniga koʻra huquqbuzardan belgilangan tartibda jarima undiriladi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7359408">(5-bandning toʻrtinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2025-yil 28-yanvardagi PF-13-sonli <a href="/ru/acts/-7345588?ONDATE=29.01.2025 00#-7351160">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.01.2025-y., 06/25/13/0080-son)</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253787">[<b>OKOZ:</b><div id="LBC8805"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.15.00 Sogʻliqni saqlash toʻgʻrisidagi qonunchilik hujjatlarini buzganlik uchun javobgarlik]</span></div></a></div><div class="ACT_TEXT"><a id="-6253787">Bunda, xarid chekida sotib olingan dori vositalari va tibbiy buyumlarning toʻliq miqdorda koʻrsatilmasligi savdo yoki xizmat koʻrsatish qoidalari toʻgʻrisidagi qonunchilikni buzish sifatida eʼtirof etiladi.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253788">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253788">6. Farmatsevtika tarmogʻini rivojlantirish agentligi 2023-yil 1-martga qadar agentlikning budjetdan tashqari mablagʻlari hisobidan dori vositalarining ishlab chiqarilishidan boshlab ularning isteʼmoli natijasigacha boʻlgan jarayonlarni nazarda tutuvchi Farmatsevtika mahsulotlari hisobi va nazorati axborot tizimini joriy etsin.</a></div><div class="ACT_TEXT"><a id="-6253789">Manfaatdor vazirlik va idoralar<a href="javascript:scrollText(-6253813)"> 2-ilovaga </a>muvofiq tasdiqlangan maʼlumotlarning Farmatsevtika mahsulotlari hisobi va nazorati axborot tizimiga integratsiya qilinishini taʼminlasin.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253790">[<b>OKOZ:</b><div id="LBC7510"><span class="iorRN">1.</span><span class="iorVal">16.00.00.00 Xavfsizlik va huquq tartibot muhofazasi / 16.04.00.00 Jamiyat xavfsizligi / 16.04.08.00 Sanitariya-epidemiologiya xavfsizligi]</span></div></a></div><div class="ACT_TEXT"><a id="-6253790">7. Sanitariya-epidemiologik osoyishtalik va jamoat salomatligi xizmati Farmatsevtika tarmogʻini rivojlantirish agentligi bilan birgalikda:</a></div><div class="ACT_TEXT"><a id="-6253791">2022-yil yakuniga qadar biologik faol qoʻshimchalarni davlat roʻyxatidan oʻtkazishda ularning xavfsizligi va tarkibini nazoratdan oʻtkazish boʻyicha Vazirlar Mahkamasiga taklif kiritsin;</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253792">[<b>OKOZ:</b><div id="LBC7278"><span class="iorRN">1.</span><span class="iorVal">12.00.00.00 Axborot va axborotlashtirish / 12.03.00.00 Axborot resurslari. Axborot resurslaridan foydalanish / 12.03.02.00 Axborotni hujjatlashtirish. Elektron hujjat aylanishi / 12.03.02.01 Elektron hujjat aylanishi]</span></div></a></div><div class="ACT_TEXT"><a id="-6253792">2023-yil 1-iyunga qadar Oʻzbekiston Respublikasida davlat roʻyxatidan oʻtkazilgan dori vositalarining tibbiyotda qoʻllanilishiga doir yoʻriqnoma hamda biologik faol qoʻshimchalarning elektron katalogini ishlab chiqsin va oʻzlarining rasmiy saytlariga joylashtirsin.</a></div><div class="ACT_TEXT"><a id="-6253793">8. Hisob palatasi Bosh prokuratura bilan birgalikda mazkur qarorda belgilangan vazifalarning toʻliq va sifatli ijro etilishi yuzasidan doimiy nazorat oʻrnatsin hamda har yarim yilda Oʻzbekiston Respublikasi Prezidenti Administratsiyasiga axborot kiritib borsin.</a></div><div class="ACT_TEXT"><a id="-6253794">9. Sogʻliqni saqlash vazirligi:</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253796">[<b>OKOZ:</b><div id="LBC18903"><span class="iorRN">1.</span><span class="iorVal">02.00.00.00 Davlat boshqaruvi asoslari / 02.08.00.00 Iqtisodiyot, ijtimoiy-madaniy qurilish sohasidagi davlat boshqaruvining umumiy masalalari / 02.08.06.00 Maʼmuriy tartib-taomillar / 02.08.06.04 Davlat xizmatlarini koʻrsatish]</span></div></a></div><div class="ACT_TEXT"><a id="-6253796">bir oy muddatda biologik faol qoʻshimchalar, oziq-ovqat qoʻshimchalari, biologik vositalar va materiallarni chetdan keltirish hamda ishlab chiqarishga Yagona interaktiv davlat xizmatlari portali orqali ruxsatnoma berish tartibini nazarda tutuvchi qaror loyihasini Vazirlar Mahkamasiga kiritsin;</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253797">[<b>OKOZ:</b><div id="LBC8803"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.01.00 Umumiy qoidalar / 14.01.01.99 Umumiy qoidalar;</span></div><div id="LBC7382"><span class="iorRN">2.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="ACT_TEXT"><a id="-6253797">ikki oy muddatda “<a href="/ru/acts/-26013">Fuqarolar sogʻligʻini saqlash toʻgʻrisida</a>”gi va “<a href="/ru/acts/-2856464">Dori vositalari va farmatsevtika faoliyati toʻgʻrisida</a>”gi Oʻzbekiston Respublikasining qonunlariga Sogʻliqni saqlash vazirligi tomonidan retseptsiz beriladigan dori vositalarining roʻyxatini tasdiqlash hamda dori moddalarini (substansiyalarni) davlat roʻyxatidan oʻtkazishni nazarda tutuvchi normani bekor qilish yuzasidan oʻzgartirishlar kiritishga doir qonun loyihasini Vazirlar Mahkamasiga kiritsin;</a></div><div class="ACT_TEXT"><a id="-6253798">uch oy muddatda manfaatdor vazirlik va idoralar bilan birgalikda qonunchilik hujjatlariga ushbu qarordan kelib chiqadigan oʻzgartirish va qoʻshimchalar toʻgʻrisida Vazirlar Mahkamasiga takliflar kiritsin.</a></div><div class="ACT_TEXT"><a id="-6253799">10. Aholini sifatli dori vositalari bilan taʼminlash yuzasidan chora-tadbirlarni amalga oshirish boʻyicha “yoʻl xaritasi” <a href="javascript:scrollText(-6253819)">3-ilovaga </a>muvofiq tasdiqlansin.</a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-6253800">[<b>OKOZ:</b><div id="LBC18934"><span class="iorRN">1.</span><span class="iorVal">21.00.00.00 Oʻzgartirish va qoʻshimchalar kiritish boʻyicha kompleks tusdagi hujjatlar / 21.02.00.00 Oʻzbekiston Respublikasi Prezidentining farmon va qarorlari;</span></div><div id="LBC18935"><span class="iorRN">2.</span><span class="iorVal">21.00.00.00 Oʻzgartirish va qoʻshimchalar kiritish boʻyicha kompleks tusdagi hujjatlar / 21.03.00.00 Oʻzbekiston Respublikasi Vazirlar Mahkamasining qarorlari]</span></div></a></div><div class="ACT_TEXT"><a id="-6253800">11. Oʻzbekiston Respublikasi Prezidentining va Oʻzbekiston Respublikasi Hukumatining ayrim hujjatlariga <a href="javascript:scrollText(-6253836)">4-ilovaga </a>muvofiq oʻzgartirish va qoʻshimchalar kiritilsin.</a></div><div class="ACT_TEXT"><a id="-6253801">12. Mazkur qaror ijrosini samarali tashkil qilishga masʼul va shaxsiy javobgar etib sogʻliqni saqlash vaziri B.A. Musayev belgilansin.</a></div><div class="ACT_TEXT"><a id="-6253802">Qaror ijrosini nazorat qilish va ijro uchun masʼul tashkilotlar faoliyatini muvofiqlashtirish Oʻzbekiston Respublikasining Bosh vaziri A.N. Aripov va Oʻzbekiston Respublikasi Prezidenti maslahatchisining birinchi oʻrinbosari L.N. Tuychiyev zimmasiga yuklansin.</a></div><div class="SIGNATURE"><a id="-6253803">Oʻzbekiston Respublikasi Prezidenti Sh. MIRZIYOYEV</a></div><div class="ACT_ESSENTIAL_ELEMENTS"><a id="-6253804">Toshkent sh.,</a></div><div class="ACT_ESSENTIAL_ELEMENTS"><a id="-6253805">2022-yil 26-oktabr,</a></div><div class="ACT_ESSENTIAL_ELEMENTS_NUM"><a id="-6253806">PQ-411-son</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7711069"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253807">Oldingi</a> tahrirga qarang.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7711069">(1-ilova Oʻzbekiston Respublikasi Prezidentining 2025-yil 19-avgustdagi PF-137-sonli <a href="/ru/acts/-7697210?ONDATE=23.08.2025 00#-7704299">Farmoniga </a>asosan oʻz kuchini yoʻqotgan — Qonunchilik maʼlumotlari milliy bazasi, 23.08.2025-y., 06/25/137/0777-son)</a></div><div class="BY_DEFAULT"><a id="-6253813"></a></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><a id="-6253814">Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-son <a href="javascript:scrollText()">qaroriga</a> <br />2-ILOVA </a></div><div class="ACT_TITLE_APPL"><a id="-6253815">Farmatsevtika mahsulotlari hisobi va nazorati axborot tizimiga integratsiya qilinadigan maʼlumotlar</a></div><div class="ACT_FORM"><a id="-6253816">ROʻYXATI</a></div><div class="BY_DEFAULT"><a id="-6253817"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6944323"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253818">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6944323"></a></div><div class="BY_DEFAULT"><a id="-6944325"><table border="1" cellpadding="0" cellspacing="0" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse" width="100%">
	<tbody>
		<tr>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
			<p align="center" style="LINE-HEIGHT: normal"><b><span style="FONT-SIZE: 12pt">T/r</span></b></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="49%">
			<p align="center" style="LINE-HEIGHT: normal"><b><span style="FONT-SIZE: 12pt">Maʼlumot berish uchun masʼul vakolatli organ</span></b></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="47%">
			<p align="center" style="LINE-HEIGHT: normal"><b><span style="FONT-SIZE: 12pt">Talab etiladigan maʼlumotlar</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
			<p align="center" style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt"><span>1.</span></span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="49%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Bandlik va mehnat munosabatlari vazirligi</span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="47%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Yagona milliy mehnat tizimi</span></p>
			</td>
		</tr>
		<tr>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
			<p align="center" style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt"><span>2.</span></span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="49%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Oʻzbekiston texnik jihatdan tartibga solish agentligi</span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="47%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Muvofiqlik sertifikatlari Davlat reyestri</span></p>
			</td>
		</tr>
		<tr>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
			<p align="center" style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt"><span>3.</span></span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="49%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Davlat soliq qoʻmitasi</span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="47%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarini raqamli markirovkalash tizimi</span></p>
			</td>
		</tr>
		<tr>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
			<p align="center" style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt"><span>4.</span></span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="49%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Personallashtirish agentligi</span></p>
			</td>
			<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="47%">
			<p style="TEXT-INDENT: 18.85pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Shaxsga doir maʼlumotlar</span></p>
			</td>
		</tr>
	</tbody>
</table></a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6944326">(2-ilova Oʻzbekiston Respublikasi Prezidentining 2024-yil 24-maydagi PF-80-sonli <a href="/ru/acts/-6937312?ONDATE=25.05.2024 00#-6939574">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 25.05.2024-y., 06/24/80/0364-son)</a></div><div class="BY_DEFAULT"><a id="-6253819"></a></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><a id="-6253820">Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-son <a href="javascript:scrollText()">qaroriga</a> <br />3-ILOVA </a></div><div class="ACT_TITLE_APPL"><a id="-6253821">Aholini sifatli dori vositalari bilan taʼminlash yuzasidan chora-tadbirlarni amalga oshirish boʻyicha</a></div><div class="ACT_FORM"><a id="-6253824">“YOʻL XARITASI”</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6532514"><a href="/ru/acts/-6252758?ONDATE=27.10.2022 00#-6253826">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6532514"></a></div><div class="BY_DEFAULT"><a id="-6532515"><table style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="1">
<tbody>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">T/r</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" width="28%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Chora-tadbirlar nomi</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" width="44%" colspan="2">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Amalga oshirish mexanizmi</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Amalga oshirish muddati</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Masʼul ijrochilar</span></b></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>1.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarini retseptsiz berishga oid tartib-taomillarni takomillashtirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarini retsept bilan va retseptsiz beriladigan dori vositalari toifasiga kiritish tartibini tasdiqlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>2.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Retseptsiz beriladigan dori vositalarining roʻyxatini rasmiy veb-saytlarda eʼlon qilish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Tibbiyot amaliyotida qoʻllashga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestrini, unda retseptsiz beriladigan dori vositalarining roʻyxatini alohida aks ettirgan holda Sogʻliqni saqlash vazirligi va Farmatsevtika tarmogʻini rivojlantirish agentligining rasmiy veb-saytlariga joylashtirish hamda muntazam yangilanib borilishini taʼminlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>3.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarini davlat roʻyxatidan oʻtkazishda klinik tadqiqotlar oʻtkazish tartibini takomillashtirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarini Oʻzbekiston Respublikasida davlat roʻyxatidan oʻtkazishda klinik tadqiqotlar oʻtkazish tartibini qayta koʻrib chiqish va tasdiqlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>4.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dorixona sharoitida dori vositalarining ulgurji realizatsiyasi yuzasidan oʻrganishlar oʻtkazish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dorixona sharoitida dori vositalarini tayyorlash uchun olingan litsenziya doirasida dorixonada tayyorlangan dori vositalarini tibbiyot muassasalarida foydalanish uchun ulgurji realizatsiya qilishga ruxsat berish boʻyicha oʻrganish oʻtkazish va natijasi yuzasidan Vazirlar Mahkamasiga taklif kiritish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Taxliliy maʼlumotlar va asoslangan takliflar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>5.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Statsionar tibbiyot tashkilotlarida bemorlarni dori vositalari va tibbiy buyumlar bilan taʼminlashni shifoxona orqali amalga oshirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Davlat tibbiy sugʻurtasi jamgʻarmasi orqali moliyalashtiriladigan respublika darajasidagi davlat statsionar tibbiyot muassasalarini dori vositalari va tibbiy buyumlar bilan taʼminlash tartibini ishlab chiqish va tasdiqlash.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Bunda, davlat tomonidan kafolatlangan tibbiy xizmatlar va dori vositalari paketi doirasidagi dori vosi?alari va tibbiy buyumlar bepul, qolgan hollarda pullik asosda, shifoxonaga kirim qilingan narxlarda berilishini nazarda tutish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>6.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Shifoxonada bemorlar tomonidan olib kelingan dori vositalari va tibbiy buyumlarni ishlatishga ruxsat beruvchi holatlarni belgilash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Alohida holatlarda shifoxonada bemorlar tomonidan olib kelingan dori vositalari va tibbiy buyumlarni ishlatishga ruxsat berish tartibini tasdiqlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>7.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2025-yil 1-yanvargacha davlat roʻyxatidan oʻtkazmasdan olib kiriladigan dori vositalari va tibbiy buyumlar roʻyxatini tasdiqlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Davlat roʻyxatidan oʻtkazmasdan, majburiy sertifikatlash sharti bilan olib kirishga ruxsat beriladigan dori vositalari va tibbiy buyumlar roʻyxatini tasdiqlash.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Davlat roʻyxatidan oʻtkazmasdan, majburiy sertifikatlash sharti bilan olib kirishga ruxsat beriladigan dori vositalari va tibbiy buyumlar roʻyxatini Sogʻliqni saqlash vazirligi va Farmatsevtika tarmogʻini rivojlantirish agentligi saytlarida eʼlon qilish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>8.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Oʻzbekiston Respublikasida davlat <span>roʻyxatidan</span> oʻtkazilgan dori vositalarining tibbiyotda qoʻllanilishiga doir yoʻriqnomalarning barcha foydalanuvchilar uchun ochiqligini taʼminlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. <span>Oʻzbekiston</span> Respublikasida davlat roʻyxatidan oʻtkazilgan dori vositalarining tibbiyotda qoʻllanilishiga doir yoʻriqnomalarni elektron shaklda tayyorlash.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Mazkur yoʻriqnomalarning katalogini yaratish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">3. Katalogni Sogʻliqni saqlash vazirligi hamda Farmatsevtika tarmogʻini rivojlantirish agentligining rasmiy veb-saytiga joylashtirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil fevral</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>9.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%" rowspan="2">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarining chakana savdosida jamoatchilik nazoratini joriy etish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: #ece9d8" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Jismoniy shaxslar tomonidan sotib olingan dori vositalari uchun dorixonalar tomonidan taqdim etiladigan xarid chekining fiskal belgisi matritsali shtrix kod (QR-kod) yordamida skanerlash orqali soliq organlarining maxsus mobil ilovasida roʻyxatdan oʻtkazilganda dori vositalari narxlarini Farmatsevtika tarmogʻini rivojlantirish agentligi axborot tizimidagi dori vositalarining chakana referent narxlari bilan avtomatik tarzda solishtirish imkonini yaratish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Bunda, Farmatsevtika tarmogʻini rivojlantirish agentligining avtomatlashtirilgan axborot tizimini soliq organlarining maxsus mobil ilovasiga integratsiya qilish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: #ece9d8" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: #ece9d8" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil aprel</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: #ece9d8" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Davlat soliq qoʻmitasi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. <span>Isteʼmolchilar huquqlarini himoya qilish uchun maxsus vakolat berilgan davlat organiga</span> murojaat kelib tushganda, murojaat holatini onlayn kuzatish imkoniyatini beruvchi elektron tizim yaratish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil aprel</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Raqobatni rivojlantirish va isteʼmolchilar huquqlarini himoya qilish, Davlat soliq qoʻmitasi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>10.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Oʻzbekiston Respublikasida ruxsat etilgan biologik faol qoʻshimchalar roʻyxatining barcha foydalanuvchilar uchun ochiqligini taʼminlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Oʻzbekiston Respublikasida ruxsat etilgan biologik faol qoʻshimchalarning elektron katalogini yaratish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Katalogni Sogʻliqni saqlash vazirligi hamda </span><span style="FONT-SIZE: 12pt">Sanitariya-epidemiologik osoyishtalik va jamoat salomatligi xizmatining</span><span style="FONT-SIZE: 12pt"> rasmiy veb-saytiga joylashtirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil may</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sanitariya-epidemiologik osoyishtalik va jamoat salomatligi xizmati,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>11.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Maxsus </span><span style="FONT-SIZE: 12pt">kiritiladigan</span><span style="FONT-SIZE: 12pt"> biologik faol qoʻshimchalar muomalasini tartibga solish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Biologik faol qoʻshimchalar, oziq-ovqat qoʻshimchalari, biologik vositalar va materiallarni chetdan keltirish hamda ishlab chiqarishga Yagona interaktiv davlat xizmatlari portali orqali ruxsatnoma berish tartibini ishlab chiqish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Normativ-huquqiy hujjat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil noyabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sanitariya-epidemiologik osoyishtalik va jamoat salomatligi xizmati, Adliya vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>12.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Shifokorlar va farmatsevtik maʼlumotga ega boʻlgan </span><span style="FONT-SIZE: 12pt">mutaxassislarni</span><span style="FONT-SIZE: 12pt"> roʻyxatdan oʻtkazish ishlarini yakunlash, roʻyxatni doimiy ravishda yangilab borish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Shifokorlar va farmatsevtik </span><span style="FONT-SIZE: 12pt">maʼlumotga</span><span style="FONT-SIZE: 12pt"> ega boʻlgan mutaxassislarni roʻyxatga olish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Umumiy foydalanish uchun ochiq boʻlgan, doimiy yangilanib boriladigan yagona elektron maʼlumotlar bazasini yuritish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>13.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Tan olish yoʻli bilan davlat roʻyxatidan oʻtkazilgan dori vositalari roʻyxatining barcha foydalanuvchilar uchun ochiqligini taʼminlash.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Tadbirkorlik subyektlari tomonidan dori vositalari, tibbiy texnika, tibbiy buyumlar va ularning butlovchi qismlarini davlat roʻyxatidan oʻtkazish uchun elektron tarzda murojaatlarini “Uzpharminfo” dasturida alohida modul orqali qabul qilish imkoniyatini yaratish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Tan olish yoʻli bilan davlat roʻyxatidan oʻtkazilgan dori vositalari reyestrini Farmatsevtika tarmogʻini rivojlantirish agentligining rasmiy saytiga joylashtirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>14.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari referent narxlarining jamoatchilik uchun ochiqligini kengaytirish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalarining referent narxlarini koʻrish va kuzatib borish imkonini beruvchi mobil ilova yaratish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Amaliy chora-tadbirlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2023-yil aprel</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt"><span>15.</span></span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="28%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari va tibbiy buyumlarni chakana realizatsiya qilishda oliy tibbiy maʼlumotga ega boʻlgan shaxslarga dorixona mudiri sifatida faoliyat yuritish huquqini berish natijalari yuzasidan oʻrganishlar oʻtkazish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="34%">
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Dori vositalari va tibbiy buyumlarni chakana realizatsiya qilishda oliy tibbiy maʼlumotga ega boʻlgan shaxslarga dorixona mudiri sifatida faoliyat yuritish huquqini berishning amaliyotdagi natijalarini tahlil qilish.</span></p>
<p style="TEXT-INDENT: 15.15pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Zarur hollarda, ushbu normani qayta koʻrib chiqish boʻyicha Vazirlar Mahkamasiga taklif kiritish.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="9%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Taxliliy maʼlumotlar va asoslangan takliflar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="8%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2022-yil dekabr</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 1.4pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 1.4pt; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmatsevtika tarmogʻini rivojlantirish agentligi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Sogʻliqni saqlash vazirligi</span></p></td></tr></tbody></table></a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6532516">(3-ilova Oʻzbekiston Respublikasi Prezidentining 2023-yil 6-iyuldagi PF-108-sonli <a href="/ru/acts/-6525087?ONDATE=07.07.2023 00#-6525497">Farmoni </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 07.07.2023-y., 06/23/108/0460-son)</a></div><div class="BY_DEFAULT"><a id="-6253836"></a></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><a id="-6253841">Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-son <a href="javascript:scrollText()">qaroriga</a> <br />4-ILOVA </a></div><div class="ACT_TITLE_APPL"><a id="-6253843">Oʻzbekiston Respublikasi Prezidentining va Oʻzbekiston Respublikasi Hukumatining ayrim hujjatlariga kiritilayotgan oʻzgartirish va qoʻshimchalar</a></div><div class="BY_DEFAULT"><a id="-6253844"></a></div><div class="ACT_TEXT"><a id="-6253845">1. Oʻzbekiston Respublikasi Prezidentining 2018-yil 24-sentabrdagi “Dori vositalarini davlat roʻyxatidan oʻtkazish tartibi va ularning aylanishini takomillashtirish boʻyicha qoʻshimcha chora-tadbirlar toʻgʻrisida”gi PQ-3948-son <a href="/ru/acts/-3914460">qarorida</a>:</a></div><div class="ACT_TEXT"><a id="-6253846">a) <a href="/ru/acts/-3914460?ONDATE=25.09.2018 00#-3921422">1-bandda </a>“va xalqaro” soʻzlari “, xalqaro va xorijiy” soʻzlari bilan almashtirilsin;</a></div><div class="ACT_TEXT"><a id="-6253847">b) ilovaning <a href="/ru/acts/-3914460?ONDATE=25.09.2018 00#-3921455">matni</a> quyidagi tahrirda bayon etilsin:</a></div><div class="BY_DEFAULT"><a id="-6253848"></a></div><div class="ACT_TITLE_APPL"><a id="-6253849">“Dori vositalarini roʻyxatdan oʻtkazish natijalari Oʻzbekiston Respublikasida tan olinadigan mamlakatlar, xalqaro va xorijiy tashkilotlar</a></div><div class="ACT_FORM"><a id="-6253850">ROʻYXATI</a></div><div class="BY_DEFAULT"><a id="-6253851"></a></div><div class="TEXT_HEADER_DEFAULT"><a id="-6253852">I. Mamlakatlar</a></div><div class="ACT_TEXT"><a id="-6253853">1. Avstraliya Ittifoqi</a></div><div class="ACT_TEXT"><a id="-6253854">2. Belgiya Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253881">3. Buyuk Britaniya va Shimoliy Irlandiya Birlashgan Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253882">4. Germaniya</a></div><div class="ACT_TEXT"><a id="-6253883">5. Daniya Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253884">6. Isroil</a></div><div class="ACT_TEXT"><a id="-6253885">7. Irlandiya</a></div><div class="ACT_TEXT"><a id="-6253886">8. Ispaniya Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253887">9. Italiya</a></div><div class="ACT_TEXT"><a id="-6253888">10. Kanada</a></div><div class="ACT_TEXT"><a id="-6253889">11. Janubiy Koreya</a></div><div class="ACT_TEXT"><a id="-6253890">12. Niderlandlar Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253891">13. Norvegiya Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253892">14. Sloveniya </a></div><div class="ACT_TEXT"><a id="-6253893">15. Amerika Qoʻshma Shtatlari</a></div><div class="ACT_TEXT"><a id="-6253894">16. Finlyandiya </a></div><div class="ACT_TEXT"><a id="-6253895">17. Fransiya </a></div><div class="ACT_TEXT"><a id="-6253896">18. Shveysariya Konfederatsiyasi</a></div><div class="ACT_TEXT"><a id="-6253897">19. Shvetsiya Qirolligi</a></div><div class="ACT_TEXT"><a id="-6253898">20. Yaponiya</a></div><div class="ACT_TEXT"><a id="-6253899">21. Vengriya</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-6253900">II. Xalqaro va xorijiy tashkilotlar</a></div><div class="ACT_TEXT"><a id="-6253902">1. Yevropa dori vositalari agentligi (YEMA), Yevropa Ittifoqi.</a></div><div class="ACT_TEXT"><a id="-6253903">2. Oziq-ovqat va dori vositalari sifati nazorati boshqarmasi (FDA), AQSH.</a></div><div class="ACT_TEXT"><a id="-6253904">3. Farmatsevtika va tibbiy buyumlar agentligi (PMDA), Yaponiya.</a></div><div class="ACT_TEXT"><a id="-6253905">4. Oziq-ovqat va dori vositalari xavfsizligi vazirligi (MFDS), Koreya Respublikasi.</a></div><div class="ACT_TEXT"><a id="-6253906">5. Dori vositalari va tibbiy buyumlar nazorati agentligi (MNRA), Buyuk Britaniya”.</a></div><div class="ACT_TEXT"><a id="-6253908">2. Oʻzbekiston Respublikasi Prezidentining 2019-yil 30-dekabrdagi “Oʻzbekiston Respublikasi farmatsevtika tarmogʻida islohotlarni chuqurlashtirishga doir qoʻshimcha chora-tadbirlar toʻgʻrisida”gi PQ-4554-son qarorining 1-bandi <a href="/ru/acts/-4673197?ONDATE=01.01.2020 00#-4676406">“a” kichik bandi </a>quyidagi mazmundagi beshinchi xatboshi bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6253909">“Tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestriga kiritilgan dori vositalarining referent narxlarini Sogʻliqni saqlash vazirligi huzuridagi Farmatsevtika tarmogʻini rivojlantirish agentligi tomonidan ariza beruvchining tegishli ariza taqdim etishidan qatʼi nazar qayd etish”.</a></div><div class="ACT_TEXT"><a id="-6253912">3. Oʻzbekiston Respublikasi Prezidentining 2020-yil 10-fevraldagi “Oʻzbekiston Respublikasida gematologiya va transfuziologiya xizmatlarini rivojlantirish hamda onkogematologik va davolash qiyin boʻlgan kasalliklarga chalingan shaxslarni yanada qoʻllab-quvvatlash chora-tadbirlari toʻgʻrisida”gi PQ-4592-son qarorining 10-bandi “b” kichik bandi <a href="/ru/acts/-4731273?ONDATE=11.02.2020 00#-4732556">ikkinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253913">“onkogematologik va davolash qiyin boʻlgan kasalliklarga chalingan bemorlarga tibbiy yordam koʻrsatish uchun tegishli tibbiyot muassasalarini qurilish va taʼmirlash, ularga asbob-uskunalar, dori vositalari, tibbiy buyumlar, laboratoriya reaktivlari va boshqa sarflash vositalarini sotib olishda”.</a></div><div class="ACT_TEXT"><a id="-6253915">4. Oʻzbekiston Respublikasi Prezidentining 2020-yil 25-noyabrdagi “Biotexnologiyalarni rivojlantirish va mamlakatning biologik xavfsizligini taʼminlash tizimini takomillashtirish boʻyicha kompleks chora-tadbirlar toʻgʻrisida”gi PQ-4899-son qaroriga <a href="/ru/acts/-5123682?ONDATE=24.02.2022 00#-5880914">5-ilovaning </a>16-pozitsiyasi “Tadbir nomi” ustuni quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253916">“Ilmiy-laboratoriya uskunalari, laboratoriya jihozlari, texnikalarning ehtiyot qismlari, butlovchi qismlar, reaktivlar, reagentlar, ozuqa muhitlari, laboratoriya idishlari, laboratoriya hayvonlari va ular uchun ozuqalar xarid qilish”.</a></div><div class="ACT_TEXT"><a id="-6253918">5. Oʻzbekiston Respublikasi Prezidentining 2021-yil 28-iyuldagi “Sogʻliqni saqlash sohasida ixtisoslashtirilgan tibbiy yordam koʻrsatish tizimini yanada takomillashtirish chora-tadbirlari toʻgʻrisida”gi PQ-5199-son <a href="/ru/acts/-5534899">qarorida</a>:</a></div><div class="ACT_TEXT"><a id="-6253919">a) <a href="/ru/acts/-5534899?ONDATE=29.07.2021 00#-5546504">1-bandda</a>:</a></div><div class="ACT_TEXT"><a id="-6253924">“a” kichik bandning <a href="/ru/acts/-5534899?ONDATE=29.07.2021 00#-5546522">sakkizinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253925">“bemor davolanganidan soʻng Davlat tibbiy sugʻurtasi jamgʻarmasi davolagan muassasaga bazaviy narxlar doirasida bemorga koʻrsatilgan tibbiy xizmatlarni asoslovchi hujjatlarga muvofiq, sarflangan mablagʻni Davlat budjeti hisobidan oʻtkazib beradi. Bunda, yoʻllanma asosida bemorlarni davolaydigan davlat tibbiyot tashkilotlari tomonidan barcha shaxslarga shoshilinch tibbiy yordam koʻrsatishda qilingan haqiqiy xarajatlar koʻrsatilgan tibbiy xizmatlarni asoslovchi hujjatlarga muvofiq Davlat tibbiy sugʻurtasi jamgʻarmasi tomonidan Davlat budjeti mablagʻlari hisobidan qoplab beriladi”;</a></div><div class="ACT_TEXT"><a id="-6253927"><a href="/ru/acts/-5534899?ONDATE=30.12.2021 02#-5811781">“g” kichik band </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253929">“g) 2022-yil 1-oktabrdan boshlab mazkur qarorga 2-ilovaga muvofiq davlat tibbiyot muassasalarida moliyalashtirishning yangi mexanizmi asosida Davlat budjeti mablagʻlari hisobidan imtiyozli toifaga kiruvchi shaxslarni elektron axborot tizimi orqali hisobga olish va navbat asosida davolanishga yoʻllash tartibi joriy etiladi. Mazkur tartib joriy etilgunga qadar ushbu davlat tibbiyot muassasalari Davlat tibbiy sugʻurtasi jamgʻarmasi orqali Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi tomonidan tasdiqlangan taqsimotga muvofiq xarajatlar tasnifining bir satrida moliyalashtiriladi. Bunda, tibbiyot muassasalari tomonidan budjet mablagʻlari hisobidan koʻrsatilgan tibbiy xizmatlar boʻyicha Davlat tibbiy sugʻurtasi jamgʻarmasiga oylik hisobot taqdim etiladi.</a></div><div class="ACT_TEXT"><a id="-6253931">Belgilansinki, mazkur qarorning 2-ilovasida nazarda tutilgan davlat tibbiyot muassasalarining shoshilinch tibbiy yordam, gemodializ, tugʻruq, bolalar va yuqumli kasalliklar boʻlinmalarini saqlash xarajatlari Sogʻliqni saqlash vazirligi tomonidan xarajatlar smetasini roʻyxatga olish asosida moliyalashtiriladi, qolgan barcha boʻlinmalarning imtiyozga ega bemorlarga koʻrsatiladigan tibbiy xizmatlar boʻyicha xarajatlari bazaviy narxlarda Davlat tibbiy sugʻurtasi jamgʻarmasi orqali qoplab beriladi”;</a></div><div class="ACT_TEXT"><a id="-6253936">quyidagi mazmundagi “d”, “e”, “j” va “z” kichik bandlar bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6253939">“d) imtiyozli toifaga kiruvchi shaxslar tibbiy xizmat koʻrsatadigan Davlat tibbiy sugʻurtasi jamgʻarmasi bilan shartnomasi mavjud davlat yoki nodavlat tibbiyot tashkilotlarini oʻz xohishiga koʻra erkin tanlash huquqiga ega boʻladi;</a></div><div class="ACT_TEXT"><a id="-6253942">e) imtiyozli toifaga kiruvchi shaxslarga Davlat budjeti mablagʻlari hisobidan tibbiy xizmat koʻrsatuvchi nodavlat tibbiyot tashkilotlariga qoʻyiladigan talablar Sogʻliqni saqlash vazirligi tomonidan tasdiqlanadi;</a></div><div class="ACT_TEXT"><a id="-6253946">j) nodavlat tibbiyot tashkilotlari tomonidan imtiyozli toifaga kiruvchi shaxslarga tibbiy xizmat koʻrsatish Davlat tibbiy sugʻurtasi jamgʻarmasi bilan tuziladigan shartnoma asosida bazaviy narxlardan kelib chiqib amalga oshiriladi;</a></div><div class="ACT_TEXT"><a id="-6253949">z) Sogʻliqni saqlash vazirligi Moliya vazirligi bilan birgalikda mazkur qarorning 2-ilovasida nazarda tutilgan davlat tibbiyot muassasalarida Davlat budjeti mablagʻlari hisobidan davolanadigan kasalliklar roʻyxatini tasdiqlaydi”;</a></div><div class="ACT_TEXT"><a id="-6253950">b) <a href="/ru/acts/-5534899?ONDATE=29.07.2021 00#-5546796">2-ilovada</a>:</a></div><div class="ACT_TEXT"><a id="-6253952"><a href="/ru/acts/-5534899?ONDATE=30.12.2021 02#-5812750">5-band </a>oʻz kuchini yoʻqotgan deb hisoblansin;</a></div><div class="ACT_TEXT"><a id="-6253954">quyidagi mazmundagi izoh bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6253957">“Izoh: amaldagi order berish tartibiga asosan rasmiylashtirilgan orderlardan 2023-yilning 1-yanvariga qadar foydalanish mumkin”.</a></div><div class="ACT_TEXT"><a id="-6253960">6. Oʻzbekiston Respublikasi Prezidentining 2021-yil 29-iyuldagi “Birlashgan Millatlar Tashkiloti Bosh Assambleyasining 2021-yil 18-maydagi “Orolboʻyi mintaqasini ekologik innovatsiyalar va texnologiyalar hududi deb eʼlon qilish toʻgʻrisida”gi maxsus rezolyutsiyasini amalga oshirish choralari toʻgʻrisida”gi PQ-5202-son qaroriga <a href="/ru/acts/-5538638?ONDATE=30.07.2021 00#-5544853">1-ilovaning </a>25-pozitsiyasi “Muddati” ustunidagi “2022-yil oktabr” soʻzlari “2023-yil oktabr” soʻzlari bilan almashtirilsin;</a></div><div class="ACT_TEXT"><a id="-6253962">7. Oʻzbekiston Respublikasi Prezidentining 2022-yil 25-apreldagi “Spinal mushak atrofiyasi tashxisi qoʻyilgan bemor bolalarga tibbiy-ijtimoiy yordam koʻrsatish va dori vositalarini bepul yetkazib berish tizimini tashkil etish chora-tadbirlari toʻgʻrisida”gi PQ-217-son <a href="/ru/acts/-5979333">qarorida</a>:</a></div><div class="ACT_TEXT"><a id="-6253965">a) 4-bandning <a href="/ru/acts/-5979333?ONDATE=25.04.2022 00#-5979639">birinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253969">“4. Sogʻliqni saqlash vazirligi 2022-yil 1-noyabrga qadar nikohlanuvchi shaxslarni molekulyar-genetik testdan hamda homilador ayollardan molekulyar-genetik diagnostika uchun olingan biomaterialni laborator tekshiruvdan oʻtkazish tartibini tasdiqlasin”;</a></div><div class="ACT_TEXT"><a id="-6253972">b) 7-bandning <a href="/ru/acts/-5979333?ONDATE=25.04.2022 00#-5979660">ikkinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6253974">“Moliya vazirligi Sogʻliqni saqlash vazirligi bilan birgalikda ushbu maqsadlar uchun 2022-yilda Davlat budjeti hisobidan qoʻshimcha 85 milliard soʻm hamda Onkogematologik va davolash qiyin boʻlgan kasalliklarga chalingan bemorlarni sogʻlomlashtirishga koʻmaklashish jamgʻarmasi hisobidan 30 milliard soʻm ajratilishini, 2023-yildan boshlab esa Davlat budjeti parametrlarida zarur mablagʻlar nazarda tutilishini taʼminlasin”.</a></div><div class="ACT_TEXT"><a id="-6253978">8. Oʻzbekiston Respublikasi Prezidentining 2022-yil 22-avgustdagi “2022-2023-yillarda axborot-kommunikatsiya texnologiyalari sohasini yangi bosqichga olib chiqish chora-tadbirlari toʻgʻrisida”gi PQ-357-son qaroriga <a href="/ru/acts/-6166539?ONDATE=23.08.2022 00#-6170274">3d-ilovaning </a>5, 6, 7, 8 va 10-pozitsiyalari “Muddati” ustunidagi “2022-yil oktabr” soʻzlari “2023-yil yanvar” soʻzlari bilan almashtirilsin.</a></div><div class="ACT_TEXT"><a id="-6253982">9. Oʻzbekiston Respublikasi Prezidentining 2022-yil 23-avgustdagi “Oʻzbekiston Respublikasi va Saudiya Arabistoni Podshohligi oʻrtasidagi koʻp qirrali hamkorlik munosabatlarini yanada kengaytirish va mustahkamlash chora-tadbirlari toʻgʻrisida”gi PQ-360-son qarorida:</a></div><div class="ACT_TEXT"><a id="-6253985">1-ilovaning 14-pozitsiyasi “Ijro etish muddatlari” ustunidagi “2022-yil 10-oktabr” soʻzlari “2022-yil 10-dekabr” soʻzlari bilan almashtirilsin;</a></div><div class="ACT_TEXT"><a id="-6253989">3-ilovaning 5-pozitsiyasi “Amalga oshirish muddati” ustunidagi “2022-yil sentabr” soʻzlari “2022-yil dekabr” soʻzlari bilan almashtirilsin.</a></div><div class="ACT_TEXT"><a id="-6253992">10. Vazirlar Mahkamasining 2017-yil 6-apreldagi 185-son qarori bilan tasdiqlangan Dori vositalarini va tibbiy buyumlarni ulgurji realizatsiya qilish tartibi toʻgʻrisidagi <a href="/ru/acts/-3155768?ONDATE=01.07.2017 00#-3155792">nizomda</a>:</a></div><div class="ACT_TEXT"><a id="-6253998">a) quyidagi mazmundagi 5<sup>1</sup>-band bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254010">“5<sup>1</sup>. Import qilinadigan dori vositalari va tibbiy buyumlar uchun xarid qiymati import mahsulotga tartibga solinadigan narx belgilash bazasi boʻlib xizmat qiladi.</a></div><div class="ACT_TEXT"><a id="-6254011">Xarid (bazaviy) qiymati quyidagi formula bilan aniqlanadi:</a></div><div class="TEXT_CENTER"><a id="-6254014"><strong>Q = Shq + B + Bx</strong>, bunda:</a></div><div class="ACT_TEXT"><a id="-6254021"><strong>Q </strong>— import qilingan dori vositalari va tibbiy buyumlarining xarid (bazaviy) qiymati;</a></div><div class="ACT_TEXT"><a id="-6254022"><strong>Shq</strong> — import qilingan dori vositalari va tibbiy buyumlarning bojxona yuk deklaratsiyasi toʻldirilgan sanadagi Markaziy bankning kursidan kelib chiqib belgilangan shartnomaviy qiymati;</a></div><div class="ACT_TEXT"><a id="-6254023"><strong>B</strong> — Markaziy bankning kursi boʻyicha belgilangan tartibda hisoblab chiqilgan bojxona toʻlovlari;</a></div><div class="ACT_TEXT"><a id="-6254024"><strong>Bx</strong> — qonunchilik hujjatlariga muvofiq shakllantiriladigan, tovarni sotib olish bilan bogʻliq boshqa xarajatlar.</a></div><div class="ACT_TEXT"><a id="-6254026">Respublika hududida ishlab chiqariladigan dori vositalari va tibbiy buyumlarning sotish qiymati Vazirlar Mahkamasining 1999-yil 5-fevraldagi 54-sonli qarori bilan tasdiqlangan Mahsulot (ishlar, xizmatlar)ni ishlab chiqarish va sotish xarajatlari tarkibi hamda moliyaviy natijalarni shakllantirish tartibi toʻgʻrisidagi nizomga muvofiq ishlab chiqaruvchilar tomonidan shakllantiriladi.</a></div><div class="ACT_TEXT"><a id="-6254029">Mahalliy ishlab chiqarilgan dori vositalari va tibbiy buyumlarning sotish qiymati ishlab chiqariladigan mahsulotga tartibga solinadigan narx belgilash bazasi boʻlib xizmat qiladi”;</a></div><div class="ACT_TEXT"><a id="-6254032">Mahalliy ishlab chiqarilgan dori vositalari va tibbiyot buyumlarining sotish qiymati mahalliy ishlab chiqariladigan mahsulotga keyinchalik qatʼiy belgilangan yoki boshqariladigan narx oʻrnatish bazasi boʻlib xizmat qiladi”.</a></div><div class="ACT_TEXT"><a id="-6254034">b) <a href="/ru/acts/-3155768?ONDATE=01.07.2017 00#-3155821">12-band </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254037">“12. Sifatsiz, qalbakilashtirilgan, Oʻzbekiston Respublikasida roʻyxatdan oʻtkazilmagan dori vositalarini va tibbiy buyumlarni, referent narxlari qayd etilmagan dori vositalarini, shuningdek, kontrafakt dori vositalarini xarid qilish hamda ulgurji realizatsiya qilish taqiqlanadi”.</a></div><div class="ACT_TEXT"><a id="-6254041">11. Vazirlar Mahkamasining 2018-yil 23-martdagi 213-son qarori bilan tasdiqlangan Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisidagi <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596059">nizomda</a>:</a></div><div class="ACT_TEXT"><a id="-6254042">a) 5-bandning <a href="/ru/acts/-3594817?ONDATE=21.09.2022 00#-6205341">ikkinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254058">“Dori vositalarini ishlab chiqarish maqsadida qoʻllaniladigan substansiyalar, dorixonalarda tayyorlanadigan dori vositalari va tibbiy buyumlar, ilmiy-tadqiqot ishlari uchun olib kiriladigan, klinik oldi tadqiqotlar, klinik tadqiqotlar oʻtkazish, koʻrgazmalarda, yarmarkalarda, xalqaro anjumanlarda namoyish etish uchun moʻljallangan dori vositalari, tibbiy buyumlar va tibbiy texnika roʻyxatdan oʻtkazilmaydi”;</a></div><div class="ACT_TEXT"><a id="-6254054">b) <a href="/ru/acts/-3594817?ONDATE=21.09.2022 00#-6205346">6-band </a>quyidagi mazmundagi ikkinchi xatboshi bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254060">“Dori vositalarini davlat roʻyxatidan oʻtkazishda ushbu dori vositasini ishlab chiqarish sharoitlarining “Zarur ishlab chiqarish amaliyoti — GMP” Oʻzbekiston Respublikasi davlat standarti talablariga muvofiqligi yuzasidan joyiga chiqqan holda farmatsevtik inspeksiya oʻtkaziladi (qonunchilik hujjatlari bilan belgilangan alohida holatlar bundan mustasno)”;</a></div><div class="ACT_TEXT"><a id="-6254061">v) <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596086">7-band </a>quyidagi mazmundagi ikkinchi va uchinchi xatboshilar bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254062">“Davlat markazi tomonidan ariza beruvchining tegishli arizasi taqdim etilishidan qatʼi nazar roʻyxatdan oʻtkazishga taqdim etilgan barcha dori vositalarining referent narxlarini qayd etish ularni davlat roʻyxatidan oʻtkazish jarayonida amalga oshiriladi.</a></div><div class="ACT_TEXT"><a id="-6254064">Davlat markazi tomonidan ariza beruvchining tegishli arizasi taqdim etilishidan qatʼi nazar Tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestriga kiritilgan barcha dori vositalarining referent narxlari qayd etiladi”;</a></div><div class="ACT_TEXT"><a id="-6254066">g) <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596095">10-bandda</a>:</a></div><div class="ACT_TEXT"><a id="-6254070"><a href="/ru/acts/-3594817?ONDATE=11.08.2019 00#-4482448">“b” kichik band </a>quyidagi tahrirda bayon etilsin: </a></div><div class="ACT_TEXT"><a id="-6254075">“b) ushbu Nizomning 3 (dori vositalari uchun) va 3a (tibbiy buyumlar va tibbiy texnika uchun) ilovalarida nazarda tutilgan ketma-ketlikda har birini alohida yuklagan holda tegishli ravishda ariza beruvchining elektron imzosi bilan tasdiqlangan dori vositalari, tibbiy buyumlar yoki tibbiy texnikani roʻyxatdan oʻtkazish hujjatlarining elektron shakli;</a></div><div class="ACT_TEXT"><a id="-6254076">d) <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596100">“d” kichik band </a>quyidagi tahrirda bayon etilsin: </a></div><div class="ACT_TEXT"><a id="-6254077">“d) faol taʼsir etuvchi moddalarning hamda yot va oʻxshash moddalarning standart namunalari, nazorat materiallari, maxsus reaktivlar va ular sifatini tasdiqlovchi hujjatlar”;</a></div><div class="ACT_TEXT"><a id="-6254140">e) 12-bandning <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596103">birinchi xatboshisi </a>quyidagi tahrirda bayon etilsin: </a></div><div class="ACT_TEXT"><a id="-6271373">“Guvohnomani olish uchun zarur boʻlgan hujjatlar Davlat markaziga elektron shaklda, Davlat markazining elektron tizimi orqali ular olinganligi haqidagi xabarnomani olgan holda taqdim etiladi. Taqdim etilgan hujjatlar ariza beruvchining elektron raqamli imzosi bilan tasdiqlanadi”;</a></div><div class="ACT_TEXT"><a id="-6254146">j) 15-bandning <a href="/ru/acts/-3594817?ONDATE=06.05.2021 00#-5426513">ikkinchi</a> va <a href="/ru/acts/-3594817?ONDATE=06.05.2021 00#-5426520">oʻn ikkinchi xatboshilaridagi </a>“tan olish yoʻli bilan roʻyxatdan oʻtkaziladigan” soʻzlaridan keyin “dori vositalari,” soʻzlari bilan toʻldirilsin;</a></div><div class="ACT_TEXT"><a id="-6254151">z)<a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596134"> 19-bandda:</a></a></div><div class="ACT_TEXT"><a id="-6254157">“g” kichik bandning <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596169">beshinchi xatboshisi </a>quyidagi tahrirda bayon etilsin: </a></div><div class="ACT_TEXT"><a id="-6254162">“dori vositalarini roʻyxatdan oʻtkazish natijalari Oʻzbekiston Respublikasida tan olinadigan mamlakatlar, xalqaro va xorijiy tashkilotlarda roʻyxatdan oʻtkazilgan dori vositalari taqdim etilganda”;</a></div><div class="ACT_TEXT"><a id="-6254165">quyidagi mazmundagi yettinchi va sakkizinchi xatboshilar bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254170">“Oʻzbekiston Respublikasi Prezidentining 2018-yil 24-sentabrdagi PQ-3948-son qarori bilan tasdiqlangan Dori vositalarini roʻyxatdan oʻtkazish natijalari Oʻzbekiston Respublikasida tan olinadigan mamlakatlar, xalqaro va xorijiy tashkilotlar roʻyxatida keltirilgan mamlakat va tashkilotlar nazorati ostida oʻtkazilgan klinik tadqiqotlarning ijobiy xulosasi mavjud boʻlganda;</a></div><div class="ACT_TEXT"><a id="-6254174">alohida dori vositalarini klinik tadqiqotlarsiz davlat roʻyxatidan oʻtkazish Sogʻliqni saqlash vazirligi tomonidan belgilangan tartibga muvofiq amalga oshiriladi”;</a></div><div class="ACT_TEXT"><a id="-6254178"><a href="/ru/acts/-3594817?ONDATE=17.08.2019 00#-5384575">yettinchi — oʻn birinchi xatboshilar </a>tegishincha toʻqqizinchi — oʻn uchinchi xatboshilar deb hisoblansin;</a></div><div class="ACT_TEXT"><a id="-6254180"><a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596198">“z” kichik band </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254182">“z) “Zarur amaliyotlar markazi” davlat unitar korxonasi:</a></div><div class="ACT_TEXT"><a id="-6254184">dori vositalari ishlab chiqaruvchi korxonalarda joyiga chiqqan holda, joyiga chiqishning imkoni boʻlmagan taqdirda masofadan (onlayn) dori vositasini ishlab chiqarish sharoitlarining “Zarur ishlab chiqarish amaliyoti (GMP)” talablariga muvofiqligi yuzasidan farmatsevtik inspeksiyalarni olib boradi;</a></div><div class="ACT_TEXT"><a id="-6254188">roʻyxatdan oʻtkazish uchun taqdim etilgan dori vositalarini ishlab chiqarish maydonining “Zarur ishlab chiqarish amaliyoti (GMP)” Oʻzbekiston Respublikasi davlat standarti talablariga muvofiqligi yuzasidan farmatsevtik inspeksiya oʻtkazish maqsadida hujjatlashtirilgan standart operatsion jarayonlar va sifat menejmenti tizimi jarayonlari roʻyxati hamda ishlab chiqarish maydonining asosiy hujjatlari (sayt master-fayl, yozma va chizma qismlarini) nusxalarini “Zarur amaliyotlar markazi” davlat unitar korxonasiga taqdim etish toʻgʻrisida ariza beruvchiga xabarnoma yuboradi;</a></div><div class="ACT_TEXT"><a id="-6254190">yuborilgan xabarnoma boʻyicha taqdim etilgan hujjatlar toʻliqligi yuzasidan ekspertiza oʻtkazadi hamda ariza beruvchi bilan farmatsevtik inspeksiya oʻtkazish boʻyicha shartnoma tuzadi;</a></div><div class="ACT_TEXT"><a id="-6254192">farmatsevtik inspeksiya oʻtkazish uchun toʻlov amalga oshirilgandan soʻng, ariza beruvchi bilan farmatsevtik inspeksiya oʻtkazish muddatlarini kelishish uchun unga inspeksiya dasturini yoʻllaydi;</a></div><div class="ACT_TEXT"><a id="-6254194">farmatsevtik inspeksiyani bevosita ishlab chiqarish maydonida oʻtkazadi hamda natijalari boʻyicha hisobot tuzadi;</a></div><div class="ACT_TEXT"><a id="-6254196">farmatsevtik inspeksiya jarayonida nomuvofiqliklar aniqlangan taqdirda, ularni bartaraf etish uchun oʻrnatilgan tartibda muddatlarni belgilaydi hamda ushbu belgilangan muddatlarda nomuvofiqliklar amalda bartaraf etilganligi holatini zaruratga koʻra joyiga chiqqan holda oʻrganadi.</a></div><div class="ACT_TEXT"><a id="-6254199">“Zarur amaliyotlar markazi” davlat unitar korxonasi tomonidan farmatsevtik inspeksiya natijalari boʻyicha ijobiy hisobot tuzilgan taqdirda, ishlab chiqaruvchiga amal qilish muddati uch yil boʻlgan sertifikat taqdim etiladi.</a></div><div class="ACT_TEXT"><a id="-6254202">Sertifikat taqdim etilgandan soʻng ariza beruvchi ishlab chiqarish maydoni menejment tizimiga taʼsir qilishi mumkin boʻlgan har qanday oʻzgarishlar haqida “Zarur amaliyotlar markazi” davlat unitar korxonasiga oʻz vaqtida xabar berishi lozim.</a></div><div class="ACT_TEXT"><a id="-6254206">“Zarur amaliyotlar markazi” davlat unitar korxonasi “Zarur ishlab chiqarish amaliyoti (GMP)” talablariga muvofiqlik yuzasidan oʻtkazilgan farmatsevtik inspeksiya natijalariga asosan dori vositalarini roʻyxatdan oʻtkazish yoki roʻyxatdan oʻtkazishni rad etish toʻgʻrisidagi xulosalarni Ekspertlar kengashiga belgilangan tartibda taqdim etadi.</a></div><div class="ACT_TEXT"><a id="-6254208">“Zarur amaliyotlar markazi” davlat unitar korxonasi quyidagi hollarda Davlat markaziga dori vositalarini roʻyxatdan oʻtkazishni rad etish boʻyicha Davlat markaziga tavsiya berishi mumkin:</a></div><div class="ACT_TEXT"><a id="-6254209">ariza beruvchi farmatsevtik inspeksiyaning bevosita ishlab chiqarish maydonida oʻtkazilishidan bosh tortganda;</a></div><div class="ACT_TEXT"><a id="-6254210">farmatsevtik inspeksiya oʻtkazish uchun talab qilingan maʼlumotlar, hujjatlar oʻrganish uchun soʻrab olinganda taqdim etilmaganda, bino va xonalarga inspektorlar kirishiga yoʻl qoʻyilmaganda;</a></div><div class="ACT_TEXT"><a id="-6254211">farmatsevtik inspeksiya mobaynida qalbaki hujjatlar va maʼlumotlar taqdim etilgani aniqlanganda;</a></div><div class="ACT_TEXT"><a id="-6254215">farmatsevtik inspeksiya natijalari boʻyicha aniqlangan nomuvofiqliklar ishlab chiqaruvchi korxona bilan kelishilgan muddatlarda toʻgʻri va toʻliq bartaraf etilmaganda.</a></div><div class="ACT_TEXT"><a id="-6254217">Farmatsevtik inspeksiyalarni oʻtkazish bilan bogʻliq xarajatlarga toʻlangan haq oʻtkazilgan farmatsevtik inspeksiya natijalaridan qatʼi nazar, ariza beruvchiga qaytarilmaydi.</a></div><div class="ACT_TEXT"><a id="-6254219">Dori vositasini ishlab chiqaruvchi farmatsevtik inspeksiya oʻtkazish maqsadida “Zarur amaliyotlar markazi” davlat unitar korxonasiga dori vositasini Oʻzbekiston Respublikasida davlat roʻyxatidan oʻtkazish jarayonidan tashqari holda (davlat roʻyxatidan oʻtkazish jarayoni bilan bogʻliq boʻlmagan holatlarda) ham murojaat qilishi mumkin.</a></div><div class="ACT_TEXT"><a id="-6254222">Inspeksiya oʻtkazilgan ishlab chiqarish maydoni GMP talablariga nomuvofiq ekanligi aniqlansa, ushbu ishlab chiqarish maydonida ilgari ishlab chiqarilgan va davlat roʻyxatidan oʻtkazilgan, muomaladagi dori vositalarini roʻyxatdan oʻtkazilganlik guvohnomasining amal qilishini toʻxtatib turish boʻyicha Ekspertlar kengashiga tavsiya beriladi.</a></div><div class="ACT_TEXT"><a id="-6254223">Roʻyxatdan oʻtkazilganlik guvohnomasining amal qilishini qayta tiklash, oʻtkazilgan farmatsevtik inspeksiya mobaynida aniqlangan barcha nomuvofiqliklar toʻliq bartaraf etilganidan soʻng, qayta farmatsevtik inspeksiya oʻtkazilib ijobiy natijalar qayd etilgan taqdirda amalga oshiriladi”;</a></div><div class="ACT_TEXT"><a id="-6254227">i) <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596299">36-band </a>quyidagi mazmundagi uchinchi xatboshi bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254228">“Guvohnomaning amal qilish muddatini uzaytirish davrida dori vositasi, tibbiy buyum va tibbiy texnikaning Oʻzbekiston Respublikasida muomalada boʻlishi toʻxtatilmaydi”;</a></div><div class="ACT_TEXT"><a id="-6254230">k) 8-bobning <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596322">nomi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254231">“Dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestri”;</a></div><div class="ACT_TEXT"><a id="-6254233">l) <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596324">40-band </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254234">“40. Davlat markazi Tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestrini yuritadi va uni oʻz rasmiy veb-saytida joylashtiradi.</a></div><div class="ACT_TEXT"><a id="-6254235">Davlat reyestrida quyidagi maʼlumotlar koʻrsatiladi:</a></div><div class="ACT_TEXT"><a id="-6254236">dori vositasining savdo nomi (dorivor oʻsimlik xom ashyosining nomi, dorivor oʻsimlikning binominal ilmiy nomi, oʻsimlik qismlari nomi, boshqa nomlar (boshqa farmakopeyada koʻrsatilgan sinonimlar) bilan beriladi);</a></div><div class="ACT_TEXT"><a id="-6254237">tibbiy buyum va tibbiy texnikaning nomi;</a></div><div class="ACT_TEXT"><a id="-6254238">dori vositasining xalqaro patentlanmagan nomi, dorining shakli, dozasi, chiqarilish shakli;</a></div><div class="ACT_TEXT"><a id="-6254239">ishlab chiqaruvchi davlatning nomi;</a></div><div class="ACT_TEXT"><a id="-6254240">ishlab chiqaruvchining (ishlab chiquvchining) nomi, uning tashkiliy-huquqiy shakli, davlati;</a></div><div class="ACT_TEXT"><a id="-6254241">dori vositalarining farmakoterapevtik guruhi, ATC (ATX, ATK) (anatomo-terapevtik-kimyoviy) kodi;</a></div><div class="ACT_TEXT"><a id="-6254242">tibbiy buyum va tibbiy texnikaning qoʻllanilish sohasi;</a></div><div class="ACT_TEXT"><a id="-6254243">guvohnoma raqami;</a></div><div class="ACT_TEXT"><a id="-6254244">guvohnoma berilgan sana;</a></div><div class="ACT_TEXT"><a id="-6254245">guvohnomaga oʻzgartirish kiritilgan sana”;</a></div><div class="ACT_TEXT"><a id="-6254246">m) 1-ilovaning <a href="/ru/acts/-3594817?ONDATE=26.03.2018 00#-3596375">matni</a> quyidagi tahrirda bayon etilsin:</a></div><div class="BY_DEFAULT"><a id="-6254248"></a></div><div class="ACT_TITLE_APPL"><a id="-6254250">“Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish</a></div><div class="ACT_FORM"><a id="-6254251">SXEMASI </a></div><div class="BY_DEFAULT"><a id="-6254252"></a></div><div class="BY_DEFAULT"><a id="-6254254"><table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
<tbody>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Bosqichlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Subyektlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Tadbirlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Bajarish muddatlari</span></b></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ariza beruvchi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikaning guvohnomasini olish uchun zarur boʻlgan hujjatlarni va namunalarni Davlat markaziga taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ariza beruvchining xohishiga koʻra</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish, roʻyxatdan oʻtkazish muddatini uzaytirish va birlamchi (dastlabki) ekspertizadan oʻtkazish uchun taqdim etilgan ariza, hujjatlar va namunalarni qabul qiladi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">5 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">3-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Davlat markazi va ariza beruvchi oʻrtasida shartnoma tuzilishini taʼminlaydi va toʻlov varaqasini rasmiylashtiradi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1) Birlamchi (dastlabki) ekspertiza oʻtkazilgandan keyin 1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Taqdim etilgan hujjatlar va namunalarni tarkibiy boʻlinmalarga hamda tegishli hujjatlar toʻplamini “Zarur amaliyotlar markazi” DUKga yuboradi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2) Ariza beruvchi tomonidan yigʻim summasi toʻlangandan keyin 1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="17">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">4-bosqich</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Davlat markazi laboratoriyalari</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Laboratoriya sinovlarini oʻtkazadi (Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari bundan mustasno), Davlat markazining boshqa tarkibiy boʻlinmalariga xulosalar taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1) Sinovlar — 65* kungacha</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2) Amal qilish muddatini uzaytirish va roʻyxatdan oʻtkazish hujjatlariga oʻzgartirishlar kiritish — 30 kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakologiya qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="8">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Taqdim etilgan hujjatlarni ekspertizadan oʻtkazadi, ularni Davlat markazi laboratoriyalarining xulosalari bilan taqqoslaydi. Roʻyxatdan oʻtkazish hujjatlariga oʻzgartirishlar kiritadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="14">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">65** kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakopeya qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Yangi tibbiy texnika qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Narkotiklar nazorati qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Taqdim etilgan hujjatlarni ekspertizadan oʻtkazadi (dori vositasining tarkibida giyohvandlik vositalari, psixotrop moddalar va prekursorlar boʻlgan hollarda).</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">“Zarur amaliyotlar markazi” DUK</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari ishlab chiqaruvchi korxonalarning “Zarur ishlab chiqarish amaliyoti (GMP)” standarti talablariga muvofiqligi yuzasidan joyiga chiqqan holda, joyiga chiqishning imkoni boʻlmagan taqdirda masofadan (onlayn) farmatsevtik inspeksiya oʻtkazadi va inspeksiya natijalari boʻyicha Ekspertlar kengashiga xulosa taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">5-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakopeya, Farmakologiya, Yangi tibbiy texnika qoʻmitalari</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikani tibbiyot amaliyotida qoʻllashga ruxsat berish yoki rad etish toʻgʻrisidagi tavsiyani Ekspertlar kengashi majlisida koʻrib chiqish va muhokama qilishga tayyorlaydi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">16*** kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="5">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">6-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ekspertlar kengashi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikani tibbiyot amaliyotida qoʻllashga ruxsat berish yoki rad etish toʻgʻrisida qaror qabul qiladi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Guvohnomani rasmiylashtiradi va ariza beruvchiga beradi (yoki yuboradi).</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr></tbody></table></a></div><div class="FOOTNOTE"><a id="-6254256">Izohlar:</a></div><div class="FOOTNOTE"><a id="-6254257">* 40 kungacha — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xom ashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olish uchun qoʻllaniladigan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar;</a></div><div class="FOOTNOTE"><a id="-6254259">20 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE"><a id="-6254260">** 40 kungacha — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xom ashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olishga moʻljallangan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar;</a></div><div class="FOOTNOTE"><a id="-6254261">36 kungacha — Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlarini roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE"><a id="-6254262">14 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE"><a id="-6254263">*** 7 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun.</a></div><div class="FOOTNOTE"><a id="-6254264">Roʻyxatdan oʻtkazish uchun umumiy belgilangan 155 kundan oshmaydigan muddatga quyidagilar kiritilmaydi:</a></div><div class="FOOTNOTE"><a id="-6254265">dori vositalari, tibbiy buyumlar va tibbiy texnikani ekspertizadan oʻtkazish jarayonida aniqlangan kamchiliklarni bartaraf etish va tegishli hujjatlarni taqdim etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="FOOTNOTE"><a id="-6254266">klinik sinovlar oʻtkazish uchun klinik bazalarga ariza beruvchi tomonidan tegishli tartibda kelishilgan klinik sinovlar dasturlarini, dori vositalari, tibbiy buyumlar va tibbiy texnika namunalarini taqdim etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="FOOTNOTE"><a id="-6254268">jenerik dori vositalarining klinik tadqiqotlarini oʻtkazishning bevosita bir yildan oshmaydigan, original dori vositalarining klinik tadqiqotlarini oʻtkazishning uch yildan oshmaydigan muddatlari.</a></div><div class="FOOTNOTE"><a id="-6254271">Dori moddalari (substansiyalar)ni va Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlarini roʻyxatdan oʻtkazishda klinik tadqiqotlar oʻtkazilmaydi.”;</a></div><div class="ACT_TEXT"><a id="-6254274">n) Nizomning rus tilidagi matni <a href="/ru/acts/3594815?ONDATE=26.03.2018 00#3596917">3-ilovasida</a>: </a></div><div class="ACT_TEXT"><a id="-6254275"><a href="/ru/acts/3594815?ONDATE=26.03.2018 00#3596949">1-qismda</a>:</a></div><div class="ACT_TEXT"><a id="-6254277"><a href="/ru/acts/3594815?ONDATE=26.03.2018 00#3596964">1.2.2.-bandi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254279">“1.2.2. Sertifikat GMP”;</a></div><div class="ACT_TEXT"><a id="-6254280"><a href="/ru/acts/3594815?ONDATE=26.03.2018 00#3596984">izoh </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254281">“Primechaniye.</a></div><div class="ACT_TEXT"><a id="-6254283">Pri uchastii v protsesse proizvodstva ryada proizvoditeley, dokumenti, ukazannie v punktax 1.3.2 i 1.3.4, predstavlyayutsya dlya vsex uchastnikov proizvodstva”;</a></div><div class="ACT_TEXT"><a id="-6254284">quyidagi mazmundagi 2-qism bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254285"><strong>“Chast 2. Obshaya texnicheskaya dokumentatsiya</strong></a></div><div class="ACT_TEXT"><a id="-6254286">2.1. Soderjaniye</a></div><div class="ACT_TEXT"><a id="-6254287">2.2. Vvedeniye v OTD (Obshuyu texnicheskuyu dokumentatsiyu)</a></div><div class="ACT_TEXT"><a id="-6254288">2.3. Obsheye rezyume po kachestvu</a></div><div class="ACT_TEXT"><a id="-6254289">2.4. Obzor doklinicheskix dannix</a></div><div class="ACT_TEXT"><a id="-6254291">2.5. Obzor klinicheskix dannix</a></div><div class="ACT_TEXT"><a id="-6254293">2.6. Rezyume po doklinicheskim issledovaniyam</a></div><div class="ACT_TEXT"><a id="-6254295">2.6.1. Rezyume farmakologicheskix dannix v tekstovom formate</a></div><div class="ACT_TEXT"><a id="-6254358">2.6.2. Rezyume farmakologicheskix dannix v vide tablits</a></div><div class="ACT_TEXT"><a id="-6254360">2.6.3. Rezyume farmakokineticheskix dannix v tekstovom formate</a></div><div class="ACT_TEXT"><a id="-6254361">2.6.4. Rezyume farmakokineticheskix dannix v vide tablits</a></div><div class="ACT_TEXT"><a id="-6254363">2.6.5. Rezyume toksikologicheskix dannix v tekstovom formate</a></div><div class="ACT_TEXT"><a id="-6254364">2.6.6. Rezyume toksikologicheskix dannix v vide tablits</a></div><div class="ACT_TEXT"><a id="-6254365">2.7. Rezyume klinicheskix dannix</a></div><div class="ACT_TEXT"><a id="-6254367">2.7.1. Rezyume biofarmatsevticheskix issledovaniy i svyazannix s nimi analiticheskix metodov</a></div><div class="ACT_TEXT"><a id="-6254368">2.7.2. Rezyume issledovaniy po klinicheskoy farmakologii</a></div><div class="ACT_TEXT"><a id="-6254369">2.7.3. Rezyume po klinicheskoy effektivnosti</a></div><div class="ACT_TEXT"><a id="-6254370">2.7.4. Rezyume po klinicheskoy bezopasnosti</a></div><div class="ACT_TEXT"><a id="-6254371">2.7.5. Kopii ispolzovannix literaturnix istochnikov</a></div><div class="ACT_TEXT"><a id="-6254372">2.7.6. Kratkiy obzor individualnix issledovaniy”;</a></div><div class="ACT_TEXT"><a id="-6254373"><a href="/ru/acts/3594815?ONDATE=26.03.2018 00#3596995">ikkinchi — toʻrtinchi qismlar </a>tegishincha uchinchi — beshinchi qismlar deb hisoblansin.</a></div><div class="ACT_TEXT"><a id="-6254382">12. Vazirlar Mahkamasining 2018-yil 24-oktabrdagi 862-son qarori bilan tasdiqlangan Oʻzbekiston Respublikasidan tashqarida amalga oshirilgan dori vositalarini roʻyxatdan oʻtkazish natijalarini tan olish tartibi toʻgʻrisidagi nizomning 10-bandi <a href="/ru/acts/-4017219?ONDATE=25.10.2018 00#-4020040">“g” kichik bandi </a>va <a href="/ru/acts/-4017219?ONDATE=25.10.2018 00#-4020050">11-bandi </a>oʻz kuchini yoʻqotgan deb hisoblansin.</a></div><div class="ACT_TEXT"><a id="-6254383">13. Vazirlar Mahkamasining 2019-yil 1-avgustdagi 641-son qarori bilan tasdiqlangan Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi huzuridagi Farmatsevtika tarmogʻini rivojlantirish agentligining Farmatsevtika tarmogʻini qoʻllab-quvvatlash va rivojlantirish jamgʻarmasi toʻgʻrisidagi nizomning<a href="/ru/acts/-4457987?ONDATE=02.08.2019 00#-4460496"> 4-bandi </a>quyidagi mazmundagi “j<sup>1</sup>” kichik band bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254385">“j<sup>1</sup>) “Zarur ishlab chiqarish amaliyoti (GMP)”ga ega mahalliy dori vositalari ishlab chiqaruvchi hamda “ISO:13485” sertifikatiga ega mahalliy tibbiy buyumlar va tibbiy texnika ishlab chiqaruvchi tashkilotlar farmatsevtika mahsulotlarining belgilangan talablarga muvofiqligi boʻyicha postmarketing nazoratini amalga oshirish xarajatlarini qoplash”.</a></div><div class="ACT_TEXT"><a id="-6254386">14. Vazirlar Mahkamasining 2019-yil 18-sentabrdagi 788-son qarori bilan tasdiqlangan Zarur amaliyotlar (GxP) talablariga muvofiqlik yuzasidan inspeksiyalar oʻtkazish tartibi toʻgʻrisidagi <a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4521824">nizomda</a>:</a></div><div class="ACT_TEXT"><a id="-6254387">a) <a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4522930">3-bandda</a>:</a></div><div class="ACT_TEXT"><a id="-6254388"><a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4522932">ikkinchi xatboshi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254389">“barcha mahalliy va xorijiy dori vositalari ishlab chiqaruvchilar Zarur ishlab chiqarish amaliyotining (GMP) milliy talablariga muvofiq”;</a></div><div class="ACT_TEXT"><a id="-6254390">quyidagi mazmundagi oltinchi xatboshi bilan toʻldirilsin:</a></div><div class="ACT_TEXT"><a id="-6254392">“farmatsevtika mahsulotlarini chakana sotish bilan shugʻullanuvchi barcha mahalliy tashkilotlar Zarur farmatsevtika (dorixona) amaliyoti (GPP) milliy talablariga muvofiq”;</a></div><div class="ACT_TEXT"><a id="-6254394">b) <a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4522984">17-bandda</a>:</a></div><div class="ACT_TEXT"><a id="-6254396"><a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4522986">uchinchi xatboshi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254397">“ariza beruvchi bilan farmatsevtik inspeksiya oʻtkazish muddatlarini kelishish uchun unga inspeksiya dasturini yoʻllash bir ish kuni ichida (xorijiy korxonalar uchun farmatsevtik inspeksiya oʻtkazuvchi inspektorlar guruhiga vizalar olingandan soʻng uch ish kuni ichida)”;</a></div><div class="ACT_TEXT"><a id="-6254399"><a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4522988">beshinchi xatboshi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254400">“oʻtkazilgan farmatsevtik inspeksiya yuzasidan hisobot tuzish va ariza beruvchiga taqdim etish oʻn ish kuni ichida, inspeksiya nazorati uchun besh ish kuni mobaynida (xorijiy korxonalar uchun oʻttiz ish kuni ichida)”;</a></div><div class="ACT_TEXT"><a id="-6254403">v) 25-bandning <a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4523004">ikkinchi xatboshisi </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254404">“Nomuvofiqliklarning amalda bartaraf etilganligi holatini oʻrganish va yakuniy hisobotni rasmiylashtirish muddati harakatlar rejasini bajarish toʻgʻrisidagi maʼlumot va nomuvofiqliklar bartaraf etilganligini tasdiqlovchi hujjatlar taqdim etilgan sanadan eʼtiboran oʻn ish kunidan oshmasligi kerak (xorijiy korxonalar uchun farmatsevtik inspeksiya oʻtkazuvchi inspektorlar guruhiga vizalar olingandan soʻng bir oy ichida)”;</a></div><div class="ACT_TEXT"><a id="-6254406">g) <a href="/ru/acts/-4520726?ONDATE=19.09.2019 00#-4523014">29-band </a>quyidagi tahrirda bayon etilsin:</a></div><div class="ACT_TEXT"><a id="-6254407">“29. Sertifikat taqdim etilgandan soʻng ishchi organ tomonidan taqdim etilgan sertifikatning amal qilish muddatini tasdiqlash maqsadida yiliga kamida bir marotaba Zarur amaliyotlar (GxP) talablari boʻyicha inspeksiya nazorati oʻtkaziladi (xorijiy korxonalar bundan mustasno)”.</a></div><br /><div class="PUBLICATION_ORIGIN"><label id="s1089"></label><a id="-6253758">(Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son; 07.07.2023-y., 06/23/108/0460-son; 25.05.2024-y., 06/24/80/0364-son; 05.12.2024-y., 07/24/408/1005-son; 29.01.2025-y., 06/25/13/0080-son; 23.08.2025-y., 06/25/137/0777-son)</a></div></div>
                
            </div>
        </section>
        
    </div>
    
    <div style="display: none;">
<!-- START WWW.UZ TOP-RATING -->
<SCRIPT language="javascript" type="text/javascript">
		<!--
		top_js = "1.0"; top_r = "id=4079&r=" + escape(document.referrer) + "&pg=" + escape(window.location.href); document.cookie = "smart_top=1; path=/"; top_r += "&c=" + (document.cookie ? "Y" : "N")
		//-->
</SCRIPT>
<SCRIPT language="javascript1.1" type="text/javascript">
<!--
		top_js = "1.1"; top_r += "&j=" + (navigator.javaEnabled() ? "Y" : "N")
//-->
</SCRIPT>
<SCRIPT language="javascript1.2" type="text/javascript">
<!--
		top_js = "1.2"; top_r += "&wh=" + screen.width + 'x' + screen.height + "&px=" + (((navigator.appName.substring(0, 3) == "Mic")) ? screen.colorDepth : screen.pixelDepth)
//-->
</SCRIPT>
<SCRIPT language="javascript1.3" type="text/javascript">
<!--
		top_js = "1.3";
//-->
</SCRIPT>
<SCRIPT language="JavaScript" type="text/javascript">
		<!--
		top_rat = "&col=0C57A6&t=ffffff&p=DD7900"; top_r += "&js=" + top_js + ""; document.write('<a href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank"><img src="https://www.uz/plugins/top_rating/count/cnt.png?' + top_r + top_rat + '" width=88 height=31 border=0 alt="Топ рейтинг www.uz"></a>')//-->
</SCRIPT>
<NOSCRIPT>
		<A href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank">
				<img height="31" src="https://www.uz/plugins/top_rating/count/nojs_cnt.png?id=4079&pg=http%3A//lex.uz&col=0C57A6&t=ffffff&p=DD7900" width="88" border="0" alt="Топ рейтинг www.uz">
		</A>
</NOSCRIPT>
<!-- FINISH WWW.UZ TOP-RATING --></div>
</body>
</html>
<script> 
    function scrollText(hash) {
        location.href = "#" + hash;
        //$('html,body').animate({
        //    scrollTop: $(window).scrollTop() - 75
        //});
    }
</script>
<script>     
    //function scrollToElement(selector, time, verticalOffset) {
    //    time = typeof (time) != 'undefined' ? time : 1000;
    //    verticalOffset = typeof (verticalOffset) != 'undefined' ? verticalOffset : 0;
    //    element = $(selector);
    //    offset = element.offset();
    //    offsetTop = offset.top + verticalOffset;
    //    $('html, body').animate({
    //        scrollTop: offsetTop
    //    }, time);
    //}

    //jQuery.fn.extend({
    //    scrollToMe: function () {
    //        var x = jQuery(this).offset().top - 100;
    //        jQuery('html,body').animate({ scrollTop: x }, 500);
    //    }
    //});

    //function opentInAct(id) {
    //    $("#" + id).scrollToMe();
    //}

    $(document).ready(function () {
        $("#theDefCssID TABLE TD").css('display', '');
    });
</script>
<style>
    #divCont > DIV {
        margin-left: -2px;
        margin-right: -2px;
        padding-left: 2px;
        padding-right: 2px;
    }

    TD.fTD {
        width: 22px;
    }

    .OFFICIAL_SOUR_TEXT {
        display: none;
    }

    /*.document_view_body*/ header {
        clear: both;
        float: left;
        height: 36px;
        width: 100%;
        background-color: #2263a9;
    }

        /*.document_view_body header .logo {
            float: left;
            padding: 0 12px;
        }*/

        /*.document_view_body header nav.main_menu {
            float: none;
        }*/

        /*nav.main_menu {
        float: left;
        padding-left: 22px;
        position: relative;
        z-index: 9;
    }*/

        /*nav.main_menu > div {
            float: left;
            height: 34px;
            margin-top: 1px;
            width: 21px;
        }*/

        /*.document_view_body header nav.main_menu > ul {
        float: none;
        font-family: helvatica;
        font-size: 11px;
    }*/

        /*nav.main_menu > ul {
        float: left;
        font-size: 16px;
    }*/

        /*nav ul, nav ol {
        list-style: none outside none;
        margin: 0;
        padding: 0;
    }*/

        /*ul, ol {
        margin: 1em 0;
        padding: 0 0 0 40px;
    }*/


        /*.document_view_body header .logo a {
        display: block;
        width: 100%;
    }*/


        /*.document_view_body*/ header .logo a span {
            background: url("/images/bg/doc_v_logo.png") no-repeat scroll center center transparent;
            display: block;
            height: 36px;
            width: 85px;
        }

    /*.hover-popup {
        display: none;
        border: 1px solid #969696;
        border-radius: 5px;
        -moz-border-radius: 5px;
        -webkit-border-radius: 5px;
        -o-border-radius: 5px;
        -ms-border-radius: 5px;
        position: absolute;
        behavior: url(css/PIE.htc);
        box-shadow: 2px 2px 6px -2px #555;
        padding: 7px;
        background: #fdffde;
        bottom: 28px;
        left: 10px;
        max-width: 500px;
        text-overflow: ellipsis;
        white-space: nowrap;
        color: #000;
        overflow: hidden;
    }*/

    /*.pre-loader {
        text-align: center;
        width: 100%;
        padding-bottom: 0 !important;
    }*/

    /*.actondate {
        width: 385px;
        height: 46px;
        background-color: White;
        z-index: 2000;
        font-family: Arial;
        font-size: 14px;
        font-weight: bold;
        opacity: 0.7;
        padding-top: 10px;
        text-align: center;
        top: 37px;
    }*/
</style>
